Recombinant Human B3GAT3 Protein，His

B3GAT3 (beta-1,3-glucuronyltransferase 3) is an enzyme that plays a crucial role in glycosaminoglycan biosynthesis, particularly in the synthesis of dermatan sulfate and heparan sulfate. These glycosaminoglycans are essential components of the extracellular matrix, influencing various biological processes, including cell signaling, growth, and development. Mutations in the B3GAT3 gene have been associated with several rare genetic disorders, such as the Ehlers-Danlos syndrome and other connective tissue disorders, marking its importance in human health. Understanding the structure and function of B3GAT3 at the molecular level is vital for elucidating its role in these diseases and for potential therapeutic interventions. Recent advances in recombinant protein technology have enabled researchers to produce B3GAT3 in heterologous systems. This has allowed for detailed studies of its enzymatic activity and interactions with donor and acceptor substrates, providing insights into its catalytic mechanisms. Furthermore, the study of B3GAT3’s role in glycan biosynthesis can lead to better comprehension of various pathological conditions related to glycosylation defects. By characterizing the recombinant B3GAT3 protein, researchers aim to develop targeted therapies that can address the underlying biochemical abnormalities associated with B3GAT3-related disorders, paving the way for novel treatments and improved patient outcomes. The continued exploration of this enzyme holds the promise of advancing our understanding of glycosaminoglycan function and the molecular underpinnings of connective tissue diseases, ultimately contributing to the broader field of glycobiology and its therapeutic applications.